Malika Kapadia, MD
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Instructor, Harvard Medical School
Image
Malika Kapadia, MD
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Instructor, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Loyola University
Chicago
IL
Medical School
Central American Health Science University
2010
Ladyville
Belize
Residency
Penn State Health Milton S. Hershey Medical Center
2014
Hershey
PA
Fellowship
Penn State Health Milton S. Hershey Medical Center
2017
Hershey
PA
Fellowship
Bone Marrow Transplant
Cancer and Blood Diseases Institute at Cincinnati Children's Hospital
2019
Cincinnati
OH
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Hematology-Oncology)
Professional History
Dr. Kapadia grew up in the suburbs of Chicago and completed her bachelor's from Loyola University. She went on to medical school, attending Central American Health Science University in Belize. She completed both her pediatric residency and her pediatric hematology / oncology fellowship at Penn State Health Milton S. Hershey Medical Center. There, very early in her training, she developed an interest in bone marrow transplant. As a result, she went on to complete her second fellowship in bone marrow transplantation at Cincinnati Children's Hospital.
Publications
Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation: Part II. Treatment Challenges, Communication Barriers, and Caregiver-Driven Approaches to Mitigation. View Abstract
Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation Part I: Integrative Analysis of Mental Health, Psychosocial Stressors, and Support Mechanisms. View Abstract
Umbilical Cord Blood Reduced Relapse but Increased Nonrelapse Mortality Compared to Matched Unrelated Donor Transplantation in Pediatric Acute Myeloid Leukemia With Active Disease: A CIBMTR 2008 to 2017 Analysis of Donor Source and Residual Disease. View Abstract
Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes. View Abstract
Induction of remission after donor lymphocyte infusion following allogeneic transplant in a case of pediatric primary myelofibrosis. View Abstract
B-cell-directed CAR T-cell therapy activates CD8+ cytotoxic CARneg bystander T cells in patients and nonhuman primates. View Abstract
A Novel Combination of Compound Heterozygous Variants in IFNGR1 Causing Complete IFNGR1 Deficiency. View Abstract
Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia. View Abstract
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study. View Abstract
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. View Abstract
Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation. View Abstract
Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study. View Abstract
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. View Abstract
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. View Abstract
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. View Abstract
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions. View Abstract
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC. View Abstract
Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. View Abstract
Safety of Surgical Fertility Preservation Procedures in Children Prior to Hematopoietic Stem Cell Transplant. View Abstract